Report Cover

Global Plasma Derived Medicine Market Insights and Forecast to 2026


Plasma Derived Medicine market is segmented , and 5. Players, stakeholders, and other participants in the global Plasma Derived Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast  and 5 for the period 2015-2026.

Segment , the Plasma Derived Medicine market is segmented into
    Albumin
    Coagulation Factor
    Immunoglobulin
    Others

Segment 5, the Plasma Derived Medicine market is segmented into
    Hospitals
    Clinics
    Other

Regional and Country-level Analysis
The Plasma Derived Medicine market is analysed and market size information is provided by regions (countries).
The key regions covered in the Plasma Derived Medicine market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, United States, Canada, Germany, France, UK, Italy, Russia, China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Brazil, Turkey, GCC Countries, Egypt, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast , and 5 segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Plasma Derived Medicine Market Share Analysis
Plasma Derived Medicine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Plasma Derived Medicine business, the date to enter into the Plasma Derived Medicine market, Plasma Derived Medicine product introduction, recent developments, etc.

The major vendors covered:
    Grifols
    SK Plasma
    Fusion Health Care
    Biotest AG
    GC Pharma
    Baxter International
    LFB
    Octapharma AG
    CSL Limited
    BPL
    China Biologic Products
    Kedrion Biopharma
    RAAS
    Tiantan Bio
    Hualan Biological Engineering
    BOYA Bio-Pharmaceutical
1 Study Coverage
    1.1 Plasma Derived Medicine Product Introduction
    1.2 Market Segments
    1.3 Key Plasma Derived Medicine Manufacturers Covered: Ranking by Revenue
    1.4 Market 
        1.4.1 Global Plasma Derived Medicine Market Size Growth Rate 
        1.4.2 Albumin
        1.4.3 Coagulation Factor
        1.4.4 Immunoglobulin
        1.4.5 Others
    1.5 Market 5
        1.5.1 Global Plasma Derived Medicine Market Size Growth Rate 5
        1.5.2 Hospitals
        1.5.3 Clinics
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Plasma Derived Medicine Market Size, Estimates and Forecasts
        2.1.1 Global Plasma Derived Medicine Revenue 2015-2026
        2.1.2 Global Plasma Derived Medicine Sales 2015-2026
    2.2 Global Plasma Derived Medicine, Market Size by Producing Regions: 2015 VS 2020 VS 2026
        2.2.1 Global Plasma Derived Medicine Retrospective Market Scenario in Sales by Region: 2015-2020
        2.2.2 Global Plasma Derived Medicine Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Plasma Derived Medicine Competitor Landscape by Players
    3.1 Plasma Derived Medicine Sales by Manufacturers
        3.1.1 Plasma Derived Medicine Sales by Manufacturers (2015-2020)
        3.1.2 Plasma Derived Medicine Sales Market Share by Manufacturers (2015-2020)
    3.2 Plasma Derived Medicine Revenue by Manufacturers
        3.2.1 Plasma Derived Medicine Revenue by Manufacturers (2015-2020)
        3.2.2 Plasma Derived Medicine Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Plasma Derived Medicine Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Plasma Derived Medicine Revenue in 2019
        3.2.5 Global Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Plasma Derived Medicine Price by Manufacturers
    3.4 Plasma Derived Medicine Manufacturing Base Distribution, Product Types
        3.4.1 Plasma Derived Medicine Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Plasma Derived Medicine Product Type
        3.4.3 Date of International Manufacturers Enter into Plasma Derived Medicine Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size  (2015-2026)
    4.1 Global Plasma Derived Medicine Market Size  (2015-2020)
        4.1.1 Global Plasma Derived Medicine Sales  (2015-2020)
        4.1.2 Global Plasma Derived Medicine Revenue  (2015-2020)
        4.1.3 Plasma Derived Medicine Average Selling Price (ASP)  (2015-2026)
    4.2 Global Plasma Derived Medicine Market Size Forecast  (2021-2026)
        4.2.1 Global Plasma Derived Medicine Sales Forecast  (2021-2026)
        4.2.2 Global Plasma Derived Medicine Revenue Forecast  (2021-2026)
        4.2.3 Plasma Derived Medicine Average Selling Price (ASP) Forecast  (2021-2026)
    4.3 Global Plasma Derived Medicine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size 5 (2015-2026)
    5.1 Global Plasma Derived Medicine Market Size 5 (2015-2020)
        5.1.1 Global Plasma Derived Medicine Sales 5 (2015-2020)
        5.1.2 Global Plasma Derived Medicine Revenue 5 (2015-2020)
        5.1.3 Plasma Derived Medicine Price 5 (2015-2020)
    5.2 Plasma Derived Medicine Market Size Forecast 5 (2021-2026)
        5.2.1 Global Plasma Derived Medicine Sales Forecast 5 (2021-2026)
        5.2.2 Global Plasma Derived Medicine Revenue Forecast 5 (2021-2026)
        5.2.3 Global Plasma Derived Medicine Price Forecast 5 (2021-2026)

6 North America
    6.1 North America Plasma Derived Medicine by Country
        6.1.1 North America Plasma Derived Medicine Sales by Country
        6.1.2 North America Plasma Derived Medicine Revenue by Country
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Plasma Derived Medicine Market Facts & Figures 
    6.3 North America Plasma Derived Medicine Market Facts & Figures 5

7 Europe
    7.1 Europe Plasma Derived Medicine by Country
        7.1.1 Europe Plasma Derived Medicine Sales by Country
        7.1.2 Europe Plasma Derived Medicine Revenue by Country
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Plasma Derived Medicine Market Facts & Figures 
    7.3 Europe Plasma Derived Medicine Market Facts & Figures 5

8 Asia Pacific
    8.1 Asia Pacific Plasma Derived Medicine by Region
        8.1.1 Asia Pacific Plasma Derived Medicine Sales by Region
        8.1.2 Asia Pacific Plasma Derived Medicine Revenue by Region
        8.1.3 China
        8.1.4 Japan
        8.1.5 South Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Thailand
        8.1.10 Malaysia
        8.1.11 Philippines
        8.1.12 Vietnam
    8.2 Asia Pacific Plasma Derived Medicine Market Facts & Figures 
    8.3 Asia Pacific Plasma Derived Medicine Market Facts & Figures 5

9 Latin America
    9.1 Latin America Plasma Derived Medicine by Country
        9.1.1 Latin America Plasma Derived Medicine Sales by Country
        9.1.2 Latin America Plasma Derived Medicine Revenue by Country
        9.1.3 Brazil
    9.2 Central & South America Plasma Derived Medicine Market Facts & Figures 
    9.3 Central & South America Plasma Derived Medicine Market Facts & Figures 5

10 Middle East and Africa
    10.1 Middle East and Africa Plasma Derived Medicine by Country
        10.1.1 Middle East and Africa Plasma Derived Medicine Sales by Country
        10.1.2 Middle East and Africa Plasma Derived Medicine Revenue by Country
        10.1.3 Turkey
        10.1.4 GCC Countries
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Plasma Derived Medicine Market Facts & Figures 
    10.3 Middle East and Africa Plasma Derived Medicine Market Facts & Figures 5

11 Company Profiles
    11.1 Grifols
        11.1.1 Grifols Corporation Information
        11.1.2 Grifols Description and Business Overview
        11.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Grifols Plasma Derived Medicine Products Offered
        11.1.5 Grifols Related Developments
    11.2 SK Plasma
        11.2.1 SK Plasma Corporation Information
        11.2.2 SK Plasma Description and Business Overview
        11.2.3 SK Plasma Sales, Revenue and Gross Margin (2015-2020)
        11.2.4 SK Plasma Plasma Derived Medicine Products Offered
        11.2.5 SK Plasma Related Developments
    11.3 Fusion Health Care
        11.3.1 Fusion Health Care Corporation Information
        11.3.2 Fusion Health Care Description and Business Overview
        11.3.3 Fusion Health Care Sales, Revenue and Gross Margin (2015-2020)
        11.3.4 Fusion Health Care Plasma Derived Medicine Products Offered
        11.3.5 Fusion Health Care Related Developments
    11.4 Biotest AG
        11.4.1 Biotest AG Corporation Information
        11.4.2 Biotest AG Description and Business Overview
        11.4.3 Biotest AG Sales, Revenue and Gross Margin (2015-2020)
        11.4.4 Biotest AG Plasma Derived Medicine Products Offered
        11.4.5 Biotest AG Related Developments
    11.5 GC Pharma
        11.5.1 GC Pharma Corporation Information
        11.5.2 GC Pharma Description and Business Overview
        11.5.3 GC Pharma Sales, Revenue and Gross Margin (2015-2020)
        11.5.4 GC Pharma Plasma Derived Medicine Products Offered
        11.5.5 GC Pharma Related Developments
    11.6 Baxter International
        11.6.1 Baxter International Corporation Information
        11.6.2 Baxter International Description and Business Overview
        11.6.3 Baxter International Sales, Revenue and Gross Margin (2015-2020)
        11.6.4 Baxter International Plasma Derived Medicine Products Offered
        11.6.5 Baxter International Related Developments
    11.7 LFB
        11.7.1 LFB Corporation Information
        11.7.2 LFB Description and Business Overview
        11.7.3 LFB Sales, Revenue and Gross Margin (2015-2020)
        11.7.4 LFB Plasma Derived Medicine Products Offered
        11.7.5 LFB Related Developments
    11.8 Octapharma AG
        11.8.1 Octapharma AG Corporation Information
        11.8.2 Octapharma AG Description and Business Overview
        11.8.3 Octapharma AG Sales, Revenue and Gross Margin (2015-2020)
        11.8.4 Octapharma AG Plasma Derived Medicine Products Offered
        11.8.5 Octapharma AG Related Developments
    11.9 CSL Limited
        11.9.1 CSL Limited Corporation Information
        11.9.2 CSL Limited Description and Business Overview
        11.9.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
        11.9.4 CSL Limited Plasma Derived Medicine Products Offered
        11.9.5 CSL Limited Related Developments
    11.10 BPL
        11.10.1 BPL Corporation Information
        11.10.2 BPL Description and Business Overview
        11.10.3 BPL Sales, Revenue and Gross Margin (2015-2020)
        11.10.4 BPL Plasma Derived Medicine Products Offered
        11.10.5 BPL Related Developments
    11.1 Grifols
        11.1.1 Grifols Corporation Information
        11.1.2 Grifols Description and Business Overview
        11.1.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
        11.1.4 Grifols Plasma Derived Medicine Products Offered
        11.1.5 Grifols Related Developments
    11.12 Kedrion Biopharma
        11.12.1 Kedrion Biopharma Corporation Information
        11.12.2 Kedrion Biopharma Description and Business Overview
        11.12.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2020)
        11.12.4 Kedrion Biopharma Products Offered
        11.12.5 Kedrion Biopharma Related Developments
    11.13 RAAS
        11.13.1 RAAS Corporation Information
        11.13.2 RAAS Description and Business Overview
        11.13.3 RAAS Sales, Revenue and Gross Margin (2015-2020)
        11.13.4 RAAS Products Offered
        11.13.5 RAAS Related Developments
    11.14 Tiantan Bio
        11.14.1 Tiantan Bio Corporation Information
        11.14.2 Tiantan Bio Description and Business Overview
        11.14.3 Tiantan Bio Sales, Revenue and Gross Margin (2015-2020)
        11.14.4 Tiantan Bio Products Offered
        11.14.5 Tiantan Bio Related Developments
    11.15 Hualan Biological Engineering
        11.15.1 Hualan Biological Engineering Corporation Information
        11.15.2 Hualan Biological Engineering Description and Business Overview
        11.15.3 Hualan Biological Engineering Sales, Revenue and Gross Margin (2015-2020)
        11.15.4 Hualan Biological Engineering Products Offered
        11.15.5 Hualan Biological Engineering Related Developments
    11.16 BOYA Bio-Pharmaceutical
        11.16.1 BOYA Bio-Pharmaceutical Corporation Information
        11.16.2 BOYA Bio-Pharmaceutical Description and Business Overview
        11.16.3 BOYA Bio-Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
        11.16.4 BOYA Bio-Pharmaceutical Products Offered
        11.16.5 BOYA Bio-Pharmaceutical Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
    12.1 Plasma Derived Medicine Market Estimates and Projections by Region
        12.1.1 Global Plasma Derived Medicine Sales Forecast by Regions 2021-2026
        12.1.2 Global Plasma Derived Medicine Revenue Forecast by Regions 2021-2026
    12.2 North America Plasma Derived Medicine Market Size Forecast (2021-2026)
        12.2.1 North America: Plasma Derived Medicine Sales Forecast (2021-2026)
        12.2.2 North America: Plasma Derived Medicine Revenue Forecast (2021-2026)
        12.2.3 North America: Plasma Derived Medicine Market Size Forecast by Country (2021-2026)
    12.3 Europe Plasma Derived Medicine Market Size Forecast (2021-2026)
        12.3.1 Europe: Plasma Derived Medicine Sales Forecast (2021-2026)
        12.3.2 Europe: Plasma Derived Medicine Revenue Forecast (2021-2026)
        12.3.3 Europe: Plasma Derived Medicine Market Size Forecast by Country (2021-2026)
    12.4 Asia Pacific Plasma Derived Medicine Market Size Forecast (2021-2026)
        12.4.1 Asia Pacific: Plasma Derived Medicine Sales Forecast (2021-2026)
        12.4.2 Asia Pacific: Plasma Derived Medicine Revenue Forecast (2021-2026)
        12.4.3 Asia Pacific: Plasma Derived Medicine Market Size Forecast by Region (2021-2026)
    12.5 Latin America Plasma Derived Medicine Market Size Forecast (2021-2026)
        12.5.1 Latin America: Plasma Derived Medicine Sales Forecast (2021-2026)
        12.5.2 Latin America: Plasma Derived Medicine Revenue Forecast (2021-2026)
        12.5.3 Latin America: Plasma Derived Medicine Market Size Forecast by Country (2021-2026)
    12.6 Middle East and Africa Plasma Derived Medicine Market Size Forecast (2021-2026)
        12.6.1 Middle East and Africa: Plasma Derived Medicine Sales Forecast (2021-2026)
        12.6.2 Middle East and Africa: Plasma Derived Medicine Revenue Forecast (2021-2026)
        12.6.3 Middle East and Africa: Plasma Derived Medicine Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Plasma Derived Medicine Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Plasma Derived Medicine Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Plasma Derived Medicine Market Segments Table 2. Ranking of Global Top Plasma Derived Medicine Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Plasma Derived Medicine Market Size Growth Rate 2020-2026 (K MT) & (US$ Million) Table 4. Major Manufacturers of Albumin Table 5. Major Manufacturers of Coagulation Factor Table 6. Major Manufacturers of Immunoglobulin Table 7. Major Manufacturers of Others Table 8. Global Plasma Derived Medicine Market Size Growth Rate 5 2020-2026 (K MT) Table 9. Global Plasma Derived Medicine Market Size by Region (K MT) & (US$ Million): 2020 VS 2026 Table 10. Global Plasma Derived Medicine Sales by Regions 2015-2020 (K MT) Table 11. Global Plasma Derived Medicine Sales Market Share by Regions (2015-2020) Table 12. Global Plasma Derived Medicine Revenue by Regions 2015-2020 (US$ Million) Table 13. Global Plasma Derived Medicine Sales by Manufacturers (2015-2020) (K MT) Table 14. Global Plasma Derived Medicine Sales Share by Manufacturers (2015-2020) Table 15. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Plasma Derived Medicine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Derived Medicine as of 2019) Table 17. Plasma Derived Medicine Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Plasma Derived Medicine Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Plasma Derived Medicine Price (2015-2020) (USD/MT) Table 20. Plasma Derived Medicine Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Plasma Derived Medicine Product Type Table 22. Date of International Manufacturers Enter into Plasma Derived Medicine Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Plasma Derived Medicine Sales (2015-2020) (K MT) Table 25. Global Plasma Derived Medicine Sales Share (2015-2020) Table 26. Global Plasma Derived Medicine Revenue (2015-2020) (US$ Million) Table 27. Global Plasma Derived Medicine Revenue Share (2015-2020) Table 28. Plasma Derived Medicine Average Selling Price (ASP) 2015-2020 (USD/MT) Table 29. Global Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 30. Global Plasma Derived Medicine Sales Share 5 (2015-2020) Table 31. North America Plasma Derived Medicine Sales by Country (2015-2020) (K MT) Table 32. North America Plasma Derived Medicine Sales Market Share by Country (2015-2020) Table 33. North America Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million) Table 34. North America Plasma Derived Medicine Revenue Market Share by Country (2015-2020) Table 35. North America Plasma Derived Medicine Sales (2015-2020) (K MT) Table 36. North America Plasma Derived Medicine Sales Market Share (2015-2020) Table 37. North America Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 38. North America Plasma Derived Medicine Sales Market Share 5 (2015-2020) Table 39. Europe Plasma Derived Medicine Sales by Country (2015-2020) (K MT) Table 40. Europe Plasma Derived Medicine Sales Market Share by Country (2015-2020) Table 41. Europe Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million) Table 42. Europe Plasma Derived Medicine Revenue Market Share by Country (2015-2020) Table 43. Europe Plasma Derived Medicine Sales (2015-2020) (K MT) Table 44. Europe Plasma Derived Medicine Sales Market Share (2015-2020) Table 45. Europe Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 46. Europe Plasma Derived Medicine Sales Market Share 5 (2015-2020) Table 47. Asia Pacific Plasma Derived Medicine Sales by Region (2015-2020) (K MT) Table 48. Asia Pacific Plasma Derived Medicine Sales Market Share by Region (2015-2020) Table 49. Asia Pacific Plasma Derived Medicine Revenue by Region (2015-2020) (US$ Million) Table 50. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region (2015-2020) Table 51. Asia Pacific Plasma Derived Medicine Sales (2015-2020) (K MT) Table 52. Asia Pacific Plasma Derived Medicine Sales Market Share (2015-2020) Table 53. Asia Pacific Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 54. Asia Pacific Plasma Derived Medicine Sales Market Share 5 (2015-2020) Table 55. Latin America Plasma Derived Medicine Sales by Country (2015-2020) (K MT) Table 56. Latin America Plasma Derived Medicine Sales Market Share by Country (2015-2020) Table 57. Latin Americaa Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million) Table 58. Latin America Plasma Derived Medicine Revenue Market Share by Country (2015-2020) Table 59. Latin America Plasma Derived Medicine Sales (2015-2020) (K MT) Table 60. Latin America Plasma Derived Medicine Sales Market Share (2015-2020) Table 61. Latin America Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 62. Latin America Plasma Derived Medicine Sales Market Share 5 (2015-2020) Table 63. Middle East and Africa Plasma Derived Medicine Sales by Country (2015-2020) (K MT) Table 64. Middle East and Africa Plasma Derived Medicine Sales Market Share by Country (2015-2020) Table 65. Middle East and Africa Plasma Derived Medicine Revenue by Country (2015-2020) (US$ Million) Table 66. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Country (2015-2020) Table 67. Middle East and Africa Plasma Derived Medicine Sales (2015-2020) (K MT) Table 68. Middle East and Africa Plasma Derived Medicine Sales Market Share (2015-2020) Table 69. Middle East and Africa Plasma Derived Medicine Sales 5 (2015-2020) (K MT) Table 70. Middle East and Africa Plasma Derived Medicine Sales Market Share 5 (2015-2020) Table 71. Grifols Corporation Information Table 72. Grifols Description and Major Businesses Table 73. Grifols Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 74. Grifols Product Table 75. Grifols Recent Development Table 76. SK Plasma Corporation Information Table 77. SK Plasma Description and Major Businesses Table 78. SK Plasma Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 79. SK Plasma Product Table 80. SK Plasma Recent Development Table 81. Fusion Health Care Corporation Information Table 82. Fusion Health Care Description and Major Businesses Table 83. Fusion Health Care Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 84. Fusion Health Care Product Table 85. Fusion Health Care Recent Development Table 86. Biotest AG Corporation Information Table 87. Biotest AG Description and Major Businesses Table 88. Biotest AG Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 89. Biotest AG Product Table 90. Biotest AG Recent Development Table 91. GC Pharma Corporation Information Table 92. GC Pharma Description and Major Businesses Table 93. GC Pharma Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 94. GC Pharma Product Table 95. GC Pharma Recent Development Table 96. Baxter International Corporation Information Table 97. Baxter International Description and Major Businesses Table 98. Baxter International Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 99. Baxter International Product Table 100. Baxter International Recent Development Table 101. LFB Corporation Information Table 102. LFB Description and Major Businesses Table 103. LFB Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 104. LFB Product Table 105. LFB Recent Development Table 106. Octapharma AG Corporation Information Table 107. Octapharma AG Description and Major Businesses Table 108. Octapharma AG Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 109. Octapharma AG Product Table 110. Octapharma AG Recent Development Table 111. CSL Limited Corporation Information Table 112. CSL Limited Description and Major Businesses Table 113. CSL Limited Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 114. CSL Limited Product Table 115. CSL Limited Recent Development Table 116. BPL Corporation Information Table 117. BPL Description and Major Businesses Table 118. BPL Plasma Derived Medicine Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 119. BPL Product Table 120. BPL Recent Development Table 121. China Biologic Products Corporation Information Table 122. China Biologic Products Description and Major Businesses Table 123. China Biologic Products Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 124. China Biologic Products Product Table 125. China Biologic Products Recent Development Table 126. Kedrion Biopharma Corporation Information Table 127. Kedrion Biopharma Description and Major Businesses Table 128. Kedrion Biopharma Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 129. Kedrion Biopharma Product Table 130. Kedrion Biopharma Recent Development Table 131. RAAS Corporation Information Table 132. RAAS Description and Major Businesses Table 133. RAAS Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 134. RAAS Product Table 135. RAAS Recent Development Table 136. Tiantan Bio Corporation Information Table 137. Tiantan Bio Description and Major Businesses Table 138. Tiantan Bio Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 139. Tiantan Bio Product Table 140. Tiantan Bio Recent Development Table 141. Hualan Biological Engineering Corporation Information Table 142. Hualan Biological Engineering Description and Major Businesses Table 143. Hualan Biological Engineering Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 144. Hualan Biological Engineering Product Table 145. Hualan Biological Engineering Recent Development Table 146. BOYA Bio-Pharmaceutical Corporation Information Table 147. BOYA Bio-Pharmaceutical Description and Major Businesses Table 148. BOYA Bio-Pharmaceutical Plasma Derived Medicine Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020) Table 149. BOYA Bio-Pharmaceutical Product Table 150. BOYA Bio-Pharmaceutical Recent Development Table 151. Global Plasma Derived Medicine Sales Forecast by Regions (2021-2026) (K MT) Table 152. Global Plasma Derived Medicine Sales Market Share Forecast by Regions (2021-2026) Table 153. Global Plasma Derived Medicine Revenue Forecast by Regions (2021-2026) (US$ Million) Table 154. Global Plasma Derived Medicine Revenue Market Share Forecast by Regions (2021-2026) Table 155. North America: Plasma Derived Medicine Sales Forecast by Country (2021-2026) (K MT) Table 156. North America: Plasma Derived Medicine Revenue Forecast by Country (2021-2026) (US$ Million) Table 157. Europe: Plasma Derived Medicine Sales Forecast by Country (2021-2026) (K MT) Table 158. Europe: Plasma Derived Medicine Revenue Forecast by Country (2021-2026) (US$ Million) Table 159. Asia Pacific: Plasma Derived Medicine Sales Forecast by Region (2021-2026) (K MT) Table 160. Asia Pacific: Plasma Derived Medicine Revenue Forecast by Region (2021-2026) (US$ Million) Table 161. Latin America: Plasma Derived Medicine Sales Forecast by Country (2021-2026) (K MT) Table 162. Latin America: Plasma Derived Medicine Revenue Forecast by Country (2021-2026) (US$ Million) Table 163. Middle East and Africa: Plasma Derived Medicine Sales Forecast by Country (2021-2026) (K MT) Table 164. Middle East and Africa: Plasma Derived Medicine Revenue Forecast by Country (2021-2026) (US$ Million) Table 165. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 166. Key Challenges Table 167. Market Risks Table 168. Main Points Interviewed from Key Plasma Derived Medicine Players Table 169. Plasma Derived Medicine Customers List Table 170. Plasma Derived Medicine Distributors List Table 171. Research Programs/Design for This Report Table 172. Key Data Information from Secondary Sources Table 173. Key Data Information from Primary Sources List of Figures Figure 1. Plasma Derived Medicine Product Picture Figure 2. Global Plasma Derived Medicine Sales Market Share in 2020 & 2026 Figure 3. Albumin Product Picture Figure 4. Coagulation Factor Product Picture Figure 5. Immunoglobulin Product Picture Figure 6. Others Product Picture Figure 7. Global Plasma Derived Medicine Sales Market Share 5 in 2020 & 2026 Figure 8. Hospitals Figure 9. Clinics Figure 10. Other Figure 11. Plasma Derived Medicine Report Years Considered Figure 12. Global Plasma Derived Medicine Market Size 2015-2026 (US$ Million) Figure 13. Global Plasma Derived Medicine Sales 2015-2026 (K MT) Figure 14. Global Plasma Derived Medicine Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Global Plasma Derived Medicine Sales Market Share by Region (2015-2020) Figure 16. Global Plasma Derived Medicine Sales Market Share by Region in 2019 Figure 17. Global Plasma Derived Medicine Revenue Market Share by Region (2015-2020) Figure 18. Global Plasma Derived Medicine Revenue Market Share by Region in 2019 Figure 19. Global Plasma Derived Medicine Sales Share by Manufacturer in 2019 Figure 20. The Top 10 and 5 Players Market Share by Plasma Derived Medicine Revenue in 2019 Figure 21. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 22. Global Plasma Derived Medicine Sales Market Share (2015-2020) Figure 23. Global Plasma Derived Medicine Sales Market Share in 2019 Figure 24. Global Plasma Derived Medicine Revenue Market Share (2015-2020) Figure 25. Global Plasma Derived Medicine Revenue Market Share in 2019 Figure 26. Global Plasma Derived Medicine Market Share by Price Range (2015-2020) Figure 27. Global Plasma Derived Medicine Sales Market Share 5 (2015-2020) Figure 28. Global Plasma Derived Medicine Sales Market Share 5 in 2019 Figure 29. Global Plasma Derived Medicine Revenue Market Share 5 (2015-2020) Figure 30. Global Plasma Derived Medicine Revenue Market Share 5 in 2019 Figure 31. North America Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT) Figure 32. North America Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million) Figure 33. North America Plasma Derived Medicine Sales Market Share by Country in 2019 Figure 34. North America Plasma Derived Medicine Revenue Market Share by Country in 2019 Figure 35. United States Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 36. United States Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Canada Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 38. Canada Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Mexico Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 40. Mexico Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. North America Plasma Derived Medicine Market Share in 2019 Figure 42. North America Plasma Derived Medicine Market Share 5 in 2019 Figure 43. Europe Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT) Figure 44. Europe Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million) Figure 45. Europe Plasma Derived Medicine Sales Market Share by Country in 2019 Figure 46. Europe Plasma Derived Medicine Revenue Market Share by Country in 2019 Figure 47. Germany Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 48. Germany Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. France Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 50. France Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. UK Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 52. UK Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Italy Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 54. Italy Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Russia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 56. Russia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Europe Plasma Derived Medicine Market Share in 2019 Figure 58. Europe Plasma Derived Medicine Market Share 5 in 2019 Figure 59. Asia Pacific Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT) Figure 60. Asia Pacific Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Plasma Derived Medicine Sales Market Share by Region in 2019 Figure 62. Asia Pacific Plasma Derived Medicine Revenue Market Share by Region in 2019 Figure 63. China Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 64. China Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 66. Japan Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 68. South Korea Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 70. India Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 72. Australia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Indonesia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 74. Indonesia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Thailand Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 76. Thailand Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Malaysia Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 78. Malaysia Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Philippines Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 80. Philippines Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Vietnam Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 82. Vietnam Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Asia Pacific Plasma Derived Medicine Market Share in 2019 Figure 84. Asia Pacific Plasma Derived Medicine Market Share 5 in 2019 Figure 85. Latin America Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT) Figure 86. Latin America Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Plasma Derived Medicine Sales Market Share by Country in 2019 Figure 88. Latin America Plasma Derived Medicine Revenue Market Share by Country in 2019 Figure 89. Brazil Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 90. Brazil Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Latin America Plasma Derived Medicine Market Share in 2019 Figure 92. Latin America Plasma Derived Medicine Market Share 5 in 2019 Figure 93. Middle East and Africa Plasma Derived Medicine Sales Growth Rate 2015-2020 (K MT) Figure 94. Middle East and Africa Plasma Derived Medicine Revenue Growth Rate 2015-2020 (US$ Million) Figure 95. Middle East and Africa Plasma Derived Medicine Sales Market Share by Country in 2019 Figure 96. Middle East and Africa Plasma Derived Medicine Revenue Market Share by Country in 2019 Figure 97. Turkey Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 98. Turkey Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 99. GCC Countries Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 100. GCC Countries Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Egypt Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 102. Egypt Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. South Africa Plasma Derived Medicine Sales Growth Rate (2015-2020) (K MT) Figure 104. South Africa Plasma Derived Medicine Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Middle East and Africa Plasma Derived Medicine Market Share in 2019 Figure 106. Middle East and Africa Plasma Derived Medicine Market Share 5 in 2019 Figure 107. North America Plasma Derived Medicine Sales Growth Rate Forecast (2021-2026) (K MT) Figure 108. North America Plasma Derived Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 109. Europe Plasma Derived Medicine Sales Growth Rate Forecast (2021-2026) (K MT) Figure 110. Europe Plasma Derived Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 111. Asia Pacific Plasma Derived Medicine Sales Growth Rate Forecast (2021-2026) (K MT) Figure 112. Asia Pacific Plasma Derived Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 113. Latin America Plasma Derived Medicine Sales Growth Rate Forecast (2021-2026) (K MT) Figure 114. Latin America Plasma Derived Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 115. Middle East and Africa Plasma Derived Medicine Sales Growth Rate Forecast (2021-2026) (K MT) Figure 116. Middle East and Africa Plasma Derived Medicine Revenue Growth Rate Forecast (2021-2026) (US$ Million) Figure 117. Porter's Five Forces Analysis Figure 118. Channels of Distribution Figure 119. Distributors Profiles Figure 120. Bottom-up and Top-down Approaches for This Report Figure 121. Data Triangulation Figure 122. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global and Japan Silica Analyzer Market Insights, Forecast to 2026

Silica Analyzer market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Silica Analyzer market will be able to gain the upper hand as they use the report as a powerful...

Global and China Transfer Membrane Market Insights, Forecast to 2026

Transfer Membrane market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Transfer Membrane market will be able to gain the upper hand as they use the report as a powe...

Global and United States Multichannel Order Management Market Size, Status and Forecast 2020-2026

Global Multichannel Order Management Scope and Market Size Multichannel Order Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multichannel Order Management market will be able t...

Global and China Aseptic sampling Market Size, Status and Forecast 2020-2026

Global Aseptic sampling Scope and Market Size Aseptic sampling market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aseptic sampling market will be able to gain the upper hand as they use the r...

Global and United States Continuous Integration Tools Market Size, Status and Forecast 2020-2026

Global Continuous Integration Tools Scope and Market Size Continuous Integration Tools market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Continuous Integration Tools market will be able to g...

Publisher: QY Research
Chat with us